U.S. FDA issues seven observations to Natco Pharma’s Chennai plant
The U.S. FDA had conducted an inspection at the API manufacturing plant in Manali, Chennai, from November 17-21
The U.S. FDA had conducted an inspection at the API manufacturing plant in Manali, Chennai, from November 17-21
What's Your Reaction?
